SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
尊敬灵萱
Lv1
40 积分
2023-10-19 加入
最近求助
最近应助
互助留言
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
9天前
已完结
Ribociclib plus Endocrine Therapy in Early Breast Cancer
10天前
已完结
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
10天前
已完结
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
10天前
已完结
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non–BRCA1/2-Mutant Cancers
10天前
已完结
Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer
10天前
已完结
Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo
12天前
已完结
CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition
12天前
已完结
Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
12天前
已完结
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms
12天前
已完结
没有进行任何应助
点赞
24天前
感谢
2个月前
时间慢【积分已退回】
2个月前
感谢
2个月前
感谢
2个月前
速度真快
2个月前
速度真快
2个月前
感谢
3个月前
速度真快
6个月前
感谢
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论